PERSPECTA

News from every angle

Back to headlines

Soleno Therapeutics Investors Offered Opportunity to Lead Securities Fraud Lawsuit

Investors in Soleno Therapeutics, Inc. (SLNO) are being offered an opportunity to lead a securities fraud class action lawsuit against the company.

25 Mar, 21:09 — 25 Mar, 21:09
PostShare